DYN
Dyne Therapeutics Inc.
$19.27
-$0.15(-0.77%)
55
Overall
60
Value
72
Tech
34
Quality
Market Cap
$1.87B
Volume
4.45M
52W Range
$6.36 - $26.69
Target Price
$35.38
EPS Estimates Overview
| Current Quarter | $-0.76 | Next Quarter | $-0.82 |
| Current Year | $-3.52 | Next Year | $-3.22 |
| QoQ Growth | -7.9% | YoY Growth | +8.5% |
| 3Y EPS CAGR | N/A | Target Price | $35.38 |
| Consensus | Buy | Upside | +83.6% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DYN | $19.27 | -0.8% | 4.45M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |